Horizon's Medical Marijuana

HMMJ-T

Analysis and Opinions about HMMJ-T

Signal
Opinion
Expert
BUY WEAKNESS
BUY WEAKNESS
June 12, 2020
The yield is not a dividend. Because of M&A, there is a capital distribution every year. Long term CBDs are going to be a big part of the future. It could be an election issue in the US. These companies don't make any money so it is speculative. He likes it longer term.
Show full opinionHide full opinion
The yield is not a dividend. Because of M&A, there is a capital distribution every year. Long term CBDs are going to be a big part of the future. It could be an election issue in the US. These companies don't make any money so it is speculative. He likes it longer term.
PARTIAL BUY
PARTIAL BUY
May 29, 2020
He started to nibble. Expect a lot of volatility. He likes it on valuation.
Show full opinionHide full opinion
He started to nibble. Expect a lot of volatility. He likes it on valuation.
PARTIAL BUY
PARTIAL BUY
January 13, 2020
He has said for a couple of years that he wants the industry to mature. He thinks there is some value there at this point. There are really no earnings, however. Usually when a correction hits, stocks without earnings get hit first. He has been buying below $9. Don't commit a lot of money. Just nibble.
Show full opinionHide full opinion
He has said for a couple of years that he wants the industry to mature. He thinks there is some value there at this point. There are really no earnings, however. Usually when a correction hits, stocks without earnings get hit first. He has been buying below $9. Don't commit a lot of money. Just nibble.
DON'T BUY
DON'T BUY
January 2, 2020
Not just discouraging performance, but catastrophic. None of these things are making any money. He won't be buying in this sector. He likes earnings.
Show full opinionHide full opinion
Not just discouraging performance, but catastrophic. None of these things are making any money. He won't be buying in this sector. He likes earnings.
DON'T BUY
DON'T BUY
December 23, 2019
The problem he has with this is that you can't get capacity. He stays away from it.
Show full opinionHide full opinion
The problem he has with this is that you can't get capacity. He stays away from it.
DON'T BUY
DON'T BUY
November 4, 2019
He's never liked marijuana stocks. The hype wasn't justified and they got way ahead of themselves. This will be regulated like alcohol which means tight returns.
Show full opinionHide full opinion
He's never liked marijuana stocks. The hype wasn't justified and they got way ahead of themselves. This will be regulated like alcohol which means tight returns.
DON'T BUY
DON'T BUY
September 6, 2019
Marijuana stocks There has been a sell off because of Canntrust and no one is making money. There will be a lot of research to be done on the benefits. However, the best days to make profit here are probably behind us.
Show full opinionHide full opinion
Marijuana stocks There has been a sell off because of Canntrust and no one is making money. There will be a lot of research to be done on the benefits. However, the best days to make profit here are probably behind us.
BUY WEAKNESS
BUY WEAKNESS
September 5, 2019
Anytime you are investing in an area with such massive potential growth opportunities, you will see volatility. If you buy a little and more yet in corrections, it is a way to play it. Wait for good stiff corrections.
Show full opinionHide full opinion
Anytime you are investing in an area with such massive potential growth opportunities, you will see volatility. If you buy a little and more yet in corrections, it is a way to play it. Wait for good stiff corrections.
BUY
BUY
August 1, 2019

HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.

Show full opinionHide full opinion

HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.

COMMENT
COMMENT
June 12, 2019
Any vice will do well, and so will this. Horizon makes great ETFs. That said, ETF's aren't always the best. Instead of buying the weed basket, buy the leader--Canopy.
Show full opinionHide full opinion
Any vice will do well, and so will this. Horizon makes great ETFs. That said, ETF's aren't always the best. Instead of buying the weed basket, buy the leader--Canopy.
DON'T BUY
DON'T BUY
June 3, 2019
Companies on this don't have any earnings. With out earnings he doesn't want it.
Show full opinionHide full opinion
Companies on this don't have any earnings. With out earnings he doesn't want it.
COMMENT
COMMENT
May 9, 2019
How does this pay a yield if weed stocks don't? It does pay a dividend, perhaps from capital gains from buying and selling those weed stocks within the ETF. He doesn't think cannabis will be an exciting industry, but will wind up like the liquor business.
Show full opinionHide full opinion
How does this pay a yield if weed stocks don't? It does pay a dividend, perhaps from capital gains from buying and selling those weed stocks within the ETF. He doesn't think cannabis will be an exciting industry, but will wind up like the liquor business.
BUY WEAKNESS
BUY WEAKNESS
April 16, 2019
This has the potential for massive growth in 20 years considering the medical applications of cannabis, but this space also has massive volatility. Buy during large declines and tiptoe in. Society is in the process of accepting marijuana. This is a sea change now.
Show full opinionHide full opinion
This has the potential for massive growth in 20 years considering the medical applications of cannabis, but this space also has massive volatility. Buy during large declines and tiptoe in. Society is in the process of accepting marijuana. This is a sea change now.
COMMENT
COMMENT
April 15, 2019
There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.
Show full opinionHide full opinion
There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.
WAIT
WAIT
March 25, 2019
X-dividend date coming up. After the next economic downturn, this will be a sector to invest in and forget it for a decade. At this point he does not see it goes above the recent highs. Don't invest in it now. You might trade it.
Show full opinionHide full opinion
X-dividend date coming up. After the next economic downturn, this will be a sector to invest in and forget it for a decade. At this point he does not see it goes above the recent highs. Don't invest in it now. You might trade it.
Showing 1 to 15 of 54 entries

Horizon's Medical Marijuana(HMMJ-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 5

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 4

Total Signals / Votes : 9

Stockchase rating for Horizon's Medical Marijuana is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Horizon's Medical Marijuana(HMMJ-T) Frequently Asked Questions

What is Horizon's Medical Marijuana stock symbol?

Horizon's Medical Marijuana is a Canadian stock, trading under the symbol HMMJ-T on the Toronto Stock Exchange (HMMJ-CT). It is usually referred to as TSX:HMMJ or HMMJ-T

Is Horizon's Medical Marijuana a buy or a sell?

In the last year, 9 stock analysts published opinions about HMMJ-T. 5 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY on WEAKNESS. Read the latest stock experts' ratings for Horizon's Medical Marijuana.

Is Horizon's Medical Marijuana a good investment or a top pick?

Horizon's Medical Marijuana was recommended as a Top Pick by Larry Berman CFA, CMT, CTA on 2020-06-12. Read the latest stock experts ratings for Horizon's Medical Marijuana.

Why is Horizon's Medical Marijuana stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Horizon's Medical Marijuana worth watching?

9 stock analysts on Stockchase covered Horizon's Medical Marijuana In the last year. It is a trending stock that is worth watching.

What is Horizon's Medical Marijuana stock price?

On 2020-07-02, Horizon's Medical Marijuana (HMMJ-T) stock closed at a price of $6.82.